David Sterman has worked as an investment analyst for nearly two decades. He started his Wall Street career in equity research at Smith Barney, culminating in a position as Senior Analyst covering European banks. While at Smith Barney, he learned of all the tricks used by Wall Street to steer the best advice to their top clients and their own trading desk.
David has also served as Managing Editor at TheStreet.com and Director of Research at Individual Investor. In addition, David worked as Director of Research for Jesup & Lamont Securities. David has made numerous media appearances over the years, primarily on CNBC and Bloomberg TV, and has a master's degree in management from Georgia Tech.
David Stermanon
Analyst Articles
Earlier this week, I looked at a range of commodity stocks that look quite attractive in relation to the value of their assets. I focused on Freeport McMoran (NYSE: FCX) as a clear example of a stock that looks quite appealing… Read More
There’s an old saying on Wall Street that investors should look to the income statement for upside and the balance sheet for downside protection. But for mining and energy stocks, this axiom has been spun on its… Read More
Investors are often faced with a clear conundrum — what to do with a stock that holds great long-term promise and stumbling near-term execution. That question has been vexing me ever since I added shares of Cree Inc. (Nasdaq: CREE) to my $100,000 Real-Money Portfolio in early January and… Read More
Randal J. Kirk is beside himself right now. The legendary biotech investor, who is now worth more than $2 billion, made a rare misstep by plunking down $14 million (at $10.61 a share) on Halozyme Therapeutics (Nasdaq: HALO) in February, only to see that investment lose a quarter of its… Read More
When it comes to stock-picking, it’s not always about finding the best company in an industry. It’s about finding the best stock in that industry. I was reminded of that axiom after poring over first-quarter results from Wells Fargo (NYSE: WFC), JP Morgan (NYSE: JPM) and Citigroup… Read More
It’s always intriguing to look at the list of the most heavily-shorted stocks. Many investors like to see which companies are expected to tumble by various short-interest gauges. Owning these stocks long-term can give pause, and perhaps a reason to sell if short sellers’ arguments appear to be on the… Read More
#-ad_banner-#Thanks to Lehman Bros., Bernie Madoff, Ivan Boesky, Dennis Kozlowski, Henry Blodget and many others, most investors have had enough. They simply don’t trust Wall Street and are convinced that the investing business is rigged for the benefit of those who know how to… Read More
Oh Argentina. Why must you frustrate us so? You’re blessed with so many resources and have so much charm. Yet you can’t help but alienate everyone that you come into contact with. #-ad_banner-#Over the last century, as nations such as Japan, South Korea, Brazil and China worked… Read More
Let’s get the bad news out of the way. Telecom firm Nokia (NYSE: NOK) has stumbled on several fronts, triggering a stop-loss in my $100,000 Real-Money Portfolio, so I’ll be selling my 800 share position 48 hours after you read this. More bad news: the recent market pullback has… Read More
As Warren Buffett, George Soros and so many others have said, you need to swim against the tide, finding values where others miss and shunning stocks that are loved by all. Back in the summer of 2010, agriculture firm Monsanto (NYSE: MON) was simply loathed. Low-cost Chinese… Read More
